TikTok Content Creators Fueling Unofficial Trade for Unapproved Weight-Loss Drug

A shadow market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and assertions of next-day UK delivery. Sellers market the drug there before directing customers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users administering products of unknown origin.

Some professionals stated the demand for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Material Elimination

Based on TikTok, the platform has removed problematic content and banned related keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with numerous of users, filled with photos of weight loss, positive reviews and detailed instructions for mixing or injecting at home.

Within minutes of entering one group, a vendor posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Information and Pricing

Inside these communities, posts display dark colored packages with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service said it actively monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has already seen patients injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to possibly significant medical dangers”.

Megan Taylor
Megan Taylor

A senior DevOps engineer with over a decade of experience in open source technologies and cloud architecture.